RPTX Stock: Repare Therapeutics Inc. Stock Price, Analysis & Insights
Get live rptx stock price $2.17, comprehensive Repare Therapeutics Inc. stock analysis, charts, news, and expert forecast. Real-time rptx stock data and investment insights.
Loading chart...
Company Overview
Repare Therapeutics Inc., a clinical-stage precision oncology company, discovers and develops therapeutics by using its synthetic lethality approach in Canada and the United States. The company uses its SNIPRx, a proprietary, genome-wide, and CRISPR-enabled platform to systematically discover and develop highly targeted cancer therapies that focuses on genomic instability, including DNA damage repair. Its lead product candidate is RP-3500, an oral small molecule inhibitor for the treatment of solid tumors with specific DNA damage repair-related genomic alterations. It is also developing RP-6306, which is under Phase I clinical trial for tumors with genetic alterations characterized by CCNE1 amplification; and Polymerase Theta program, a SL target associated with BRCA mutations and other genomic alterations. The company was incorporated in 2016 and is headquartered in Montreal, Canada.
Company Information
- CEO
- Steve Forte CPA
- Sector
- Healthcare
- Industry
- Biotechnology
- Employees
- 129
Contact Information
- Website
- https://www.reparerx.com
- Address
- 7210 Frederick-Banting
- Country
- CA
Investment Analysis & Business Insights
Investment Highlights
✓ Strong presence in the Healthcare sector with established market position
Business Model & Strategy
Repare Therapeutics Inc. operates in the Biotechnology industry, focusing on medical services, pharmaceutical development, and healthcare delivery. Under the leadership of CEO Steve Forte CPA, the company navigates Healthcare sector dynamics while pursuing growth opportunities. The Biotechnology model requires regulatory compliance, research investment, and patient outcomes to maintain competitiveness and drive shareholder value.
Market Position & Competitive Landscape
Repare Therapeutics Inc. competes in the Biotechnology within the broader Healthcare. With 93.3 million in market capitalization, the company is positioned as a emerging competitor in its sector. The Healthcare is characterized by demographic shifts, regulatory changes, and medical breakthroughs. As a publicly traded company on the NASDAQ Global Select, Repare Therapeutics Inc. provides investors with liquidity and transparency while subject to regulatory oversight. Investors evaluating Repare Therapeutics Inc. should consider industry-specific trends, competitive positioning, and Healthcare sector fundamentals.
Important Investment Considerations
- ⚠All investments carry risk, including potential loss of principal for Repare Therapeutics Inc. shareholders
- ⚠Market volatility can significantly impact stock price, especially for smaller companies
- ⚠Sector-specific risks in Healthcare may affect company performance
- ⚠Past performance does not guarantee future results for Repare Therapeutics Inc.
- ⚠Investors should consider how Repare Therapeutics Inc. fits within their overall portfolio allocation
- ⚠Valuation metrics suggest potential, but require fundamental analysis
Market Cap
93.32M
P/E Ratio
-0.84
Beta
1.04
Investment Analysis & Insights
Key Investment Highlights
- Market Position: Healthcare leader with 93.32M market capitalization
- Trading Volume: 264.91K shares traded today
- Price Range: 52-week range of $0.89 - $4.07
- Exchange: Listed on NASDAQ Global Select
Financial Metrics
Market Analysis for Repare Therapeutics Inc.
Repare Therapeutics Inc. (RPTX) operates in the Biotechnology industry within the Healthcare sector. With a current market capitalization of 93.32M, the company represents a significant player in its market. The stock is currently trading at $2.17 with a negativedaily change of 0.35%.
The company's 129 employee base and presence on the NASDAQ Global Selectexchange position it as a Healthcare sector leader. Investors should consider the stock's P/E ratio of -0.84, beta of 1.04, and 52-week price range from $0.89 to $4.07when evaluating investment opportunities.
Why Invest in Repare Therapeutics Inc.?
Strengths
- • Established market presence in Healthcare
- • Strong financial metrics and market position
- • Listed on major exchange (NASDAQ Global Select)
- • Experienced leadership under Steve Forte CPA
Investment Considerations
- • Monitor sector-specific market trends
- • Track quarterly earnings performance
- • Consider market volatility and beta
- • Evaluate long-term growth potential
Related Healthcare Stocks
About Healthcare Sector
The Healthcare sector includes companies that provide medical services, develop pharmaceuticals, manufacture medical devices, and offer health insurance.